Trial intelligence / Profile preview

Fluconazole plus vaginal lactobacillus in diabetic women with vulvovaginal candidiasis

IRCT20180612040071N1Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of fluconazole in vulvovaginal candidiasis (VVC), sponsored by Kashan University of Medical Sciences. Started Sep 2019; status: completed.

02

Drugs

fluconazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on IRCT20180612040071N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180612040071N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call